No Cover Image

Journal article 866 views

ACTN3 R577x genotype is not associated with elite european caucasian marathon performance

Adam J Herbert, Alun G Williams, Sarah J Lockey, Robert M Erskine, Shane Heffernan Orcid Logo, Charles R Pedlar, Courtney Kipps, Stephen H Day, Georgina K Stebbings

British Journal of Sports Medicine, Volume: 50, Issue: Suppl 1, Pages: A53.2 - A54

Swansea University Author: Shane Heffernan Orcid Logo

Full text not available from this repository: check for access using links below.

Abstract

Objectives A common nonsense polymorphism (R577X) in the ACTN3 (α-actinin-3 protein) has been associated with elite athlete status previously. Specifically, the X allele has been positively associated with elite endurance status, however, this remains inconclusive due to contradictory reports within...

Full description

Published in: British Journal of Sports Medicine
ISSN: 0306-3674 1473-0480
Published: 2016
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa51454
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2019-08-16T15:30:36Z
last_indexed 2019-09-04T14:49:17Z
id cronfa51454
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2019-09-04T11:35:47.3471152</datestamp><bib-version>v2</bib-version><id>51454</id><entry>2019-08-16</entry><title>ACTN3 R577x genotype is not associated with elite european caucasian marathon performance</title><swanseaauthors><author><sid>72c0b36891dfbec0378c0d0f7916e807</sid><ORCID>0000-0002-3297-9335</ORCID><firstname>Shane</firstname><surname>Heffernan</surname><name>Shane Heffernan</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2019-08-16</date><deptcode>STSC</deptcode><abstract>Objectives A common nonsense polymorphism (R577X) in the ACTN3 (&#x3B1;-actinin-3 protein) has been associated with elite athlete status previously. Specifically, the X allele has been positively associated with elite endurance status, however, this remains inconclusive due to contradictory reports within the literature. Thus, the current study aimed to compare ACTN3 R577X genotype and allele frequency distributions in &#x2018;elite&#x2019; and &#x2018;sub-elite&#x2019; marathon runners with those of a non-athletic, control population and to determine whether marathon personal best time was associated with ACTN3 R577X genotype.Method Four hundred and eighty four elite and sub-elite European Caucasian marathon runners and 554 ethnically matched controls provided a DNA sample from which the ACTN3 R577X polymorphism was genotyped using real-time PCR. Personal best (PB) times were used to determine elite (men &lt; 2 h 30 min, n = 111; women &lt; 3 h 00 min, n = 105) or sub-elite (men 2 h 30 min &#x2013; 2 h 45 min, n = 189; women 3 h 00 min &#x2013; 3 h 15 min, n = 79) status. Genotype and allele frequencies were compared between athletes and controls using Chi-square analyses. One-way ANOVAs were implemented to identify any genotype-dependent differences in PB times for men and women, which were subject to correction for multiple comparisons.Results The X allele was &#x223C;3% more frequent in the marathon runners than in non-athlete controls (see Table 1 and Figure 1), although this small difference did not approach statistical significance. There were no significant differences in genotype (&#x3C7;2 = 3.40; P = 0.182) or allele (&#x3C7;2 = 2.31; P = 0.128) frequency distributions between athletes (RR = 29.1%, RX = 50.6% XX = 20.2%; R = 54.4%, X = 45.6%) and controls. There were also no differences between elite and sub-elite genotype (P = 0.968, &#x3C7;2 = 0.66) and allele frequencies (P = 0.916, &#x3C7;2 = 0.11). Similarly, no differences in genotype or allele frequencies were found between either elite (P = 0.439, &#x3C7;2 = 1.65; P = 0.265, &#x3C7;2 = 1.24) or sub-elite (P = 0.254, &#x3C7;2 = 2.74; P = 0.183, &#x3C7;2 = 1.77) runners and the control group. Neither were PB times genotype-dependent for either men (P = 0.864) or women (P = 0.966).Conclusion No differences in genotype and allele frequencies were observed between athletes and controls, elite vs sub-elite, nor elite and sub-elite comparisons with the control group. Additionally, there was no genotype-dependent influence on PB time, which further emphasises that the ACTN3 R577X polymorphism does not influence elite endurance athlete status or determine marathon performance in European Caucasian runners. This is congruent with some previous findings and suggests other genetic variants or environmental factors may play a more prominent role in achieving elite endurance athlete status.</abstract><type>Journal Article</type><journal>British Journal of Sports Medicine</journal><volume>50</volume><journalNumber>Suppl 1</journalNumber><paginationStart>A53.2</paginationStart><paginationEnd>A54</paginationEnd><publisher/><issnPrint>0306-3674</issnPrint><issnElectronic>1473-0480</issnElectronic><keywords/><publishedDay>18</publishedDay><publishedMonth>11</publishedMonth><publishedYear>2016</publishedYear><publishedDate>2016-11-18</publishedDate><doi>10.1136/bjsports-2016-097120.94</doi><url/><notes/><college>COLLEGE NANME</college><department>Sport and Exercise Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>STSC</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2019-09-04T11:35:47.3471152</lastEdited><Created>2019-08-16T11:39:30.6093635</Created><path><level id="1">Faculty of Science and Engineering</level><level id="2">School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences</level></path><authors><author><firstname>Adam J</firstname><surname>Herbert</surname><order>1</order></author><author><firstname>Alun G</firstname><surname>Williams</surname><order>2</order></author><author><firstname>Sarah J</firstname><surname>Lockey</surname><order>3</order></author><author><firstname>Robert M</firstname><surname>Erskine</surname><order>4</order></author><author><firstname>Shane</firstname><surname>Heffernan</surname><orcid>0000-0002-3297-9335</orcid><order>5</order></author><author><firstname>Charles R</firstname><surname>Pedlar</surname><order>6</order></author><author><firstname>Courtney</firstname><surname>Kipps</surname><order>7</order></author><author><firstname>Stephen H</firstname><surname>Day</surname><order>8</order></author><author><firstname>Georgina K</firstname><surname>Stebbings</surname><order>9</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2019-09-04T11:35:47.3471152 v2 51454 2019-08-16 ACTN3 R577x genotype is not associated with elite european caucasian marathon performance 72c0b36891dfbec0378c0d0f7916e807 0000-0002-3297-9335 Shane Heffernan Shane Heffernan true false 2019-08-16 STSC Objectives A common nonsense polymorphism (R577X) in the ACTN3 (α-actinin-3 protein) has been associated with elite athlete status previously. Specifically, the X allele has been positively associated with elite endurance status, however, this remains inconclusive due to contradictory reports within the literature. Thus, the current study aimed to compare ACTN3 R577X genotype and allele frequency distributions in ‘elite’ and ‘sub-elite’ marathon runners with those of a non-athletic, control population and to determine whether marathon personal best time was associated with ACTN3 R577X genotype.Method Four hundred and eighty four elite and sub-elite European Caucasian marathon runners and 554 ethnically matched controls provided a DNA sample from which the ACTN3 R577X polymorphism was genotyped using real-time PCR. Personal best (PB) times were used to determine elite (men < 2 h 30 min, n = 111; women < 3 h 00 min, n = 105) or sub-elite (men 2 h 30 min – 2 h 45 min, n = 189; women 3 h 00 min – 3 h 15 min, n = 79) status. Genotype and allele frequencies were compared between athletes and controls using Chi-square analyses. One-way ANOVAs were implemented to identify any genotype-dependent differences in PB times for men and women, which were subject to correction for multiple comparisons.Results The X allele was ∼3% more frequent in the marathon runners than in non-athlete controls (see Table 1 and Figure 1), although this small difference did not approach statistical significance. There were no significant differences in genotype (χ2 = 3.40; P = 0.182) or allele (χ2 = 2.31; P = 0.128) frequency distributions between athletes (RR = 29.1%, RX = 50.6% XX = 20.2%; R = 54.4%, X = 45.6%) and controls. There were also no differences between elite and sub-elite genotype (P = 0.968, χ2 = 0.66) and allele frequencies (P = 0.916, χ2 = 0.11). Similarly, no differences in genotype or allele frequencies were found between either elite (P = 0.439, χ2 = 1.65; P = 0.265, χ2 = 1.24) or sub-elite (P = 0.254, χ2 = 2.74; P = 0.183, χ2 = 1.77) runners and the control group. Neither were PB times genotype-dependent for either men (P = 0.864) or women (P = 0.966).Conclusion No differences in genotype and allele frequencies were observed between athletes and controls, elite vs sub-elite, nor elite and sub-elite comparisons with the control group. Additionally, there was no genotype-dependent influence on PB time, which further emphasises that the ACTN3 R577X polymorphism does not influence elite endurance athlete status or determine marathon performance in European Caucasian runners. This is congruent with some previous findings and suggests other genetic variants or environmental factors may play a more prominent role in achieving elite endurance athlete status. Journal Article British Journal of Sports Medicine 50 Suppl 1 A53.2 A54 0306-3674 1473-0480 18 11 2016 2016-11-18 10.1136/bjsports-2016-097120.94 COLLEGE NANME Sport and Exercise Sciences COLLEGE CODE STSC Swansea University 2019-09-04T11:35:47.3471152 2019-08-16T11:39:30.6093635 Faculty of Science and Engineering School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences Adam J Herbert 1 Alun G Williams 2 Sarah J Lockey 3 Robert M Erskine 4 Shane Heffernan 0000-0002-3297-9335 5 Charles R Pedlar 6 Courtney Kipps 7 Stephen H Day 8 Georgina K Stebbings 9
title ACTN3 R577x genotype is not associated with elite european caucasian marathon performance
spellingShingle ACTN3 R577x genotype is not associated with elite european caucasian marathon performance
Shane Heffernan
title_short ACTN3 R577x genotype is not associated with elite european caucasian marathon performance
title_full ACTN3 R577x genotype is not associated with elite european caucasian marathon performance
title_fullStr ACTN3 R577x genotype is not associated with elite european caucasian marathon performance
title_full_unstemmed ACTN3 R577x genotype is not associated with elite european caucasian marathon performance
title_sort ACTN3 R577x genotype is not associated with elite european caucasian marathon performance
author_id_str_mv 72c0b36891dfbec0378c0d0f7916e807
author_id_fullname_str_mv 72c0b36891dfbec0378c0d0f7916e807_***_Shane Heffernan
author Shane Heffernan
author2 Adam J Herbert
Alun G Williams
Sarah J Lockey
Robert M Erskine
Shane Heffernan
Charles R Pedlar
Courtney Kipps
Stephen H Day
Georgina K Stebbings
format Journal article
container_title British Journal of Sports Medicine
container_volume 50
container_issue Suppl 1
container_start_page A53.2
publishDate 2016
institution Swansea University
issn 0306-3674
1473-0480
doi_str_mv 10.1136/bjsports-2016-097120.94
college_str Faculty of Science and Engineering
hierarchytype
hierarchy_top_id facultyofscienceandengineering
hierarchy_top_title Faculty of Science and Engineering
hierarchy_parent_id facultyofscienceandengineering
hierarchy_parent_title Faculty of Science and Engineering
department_str School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences{{{_:::_}}}Faculty of Science and Engineering{{{_:::_}}}School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences
document_store_str 0
active_str 0
description Objectives A common nonsense polymorphism (R577X) in the ACTN3 (α-actinin-3 protein) has been associated with elite athlete status previously. Specifically, the X allele has been positively associated with elite endurance status, however, this remains inconclusive due to contradictory reports within the literature. Thus, the current study aimed to compare ACTN3 R577X genotype and allele frequency distributions in ‘elite’ and ‘sub-elite’ marathon runners with those of a non-athletic, control population and to determine whether marathon personal best time was associated with ACTN3 R577X genotype.Method Four hundred and eighty four elite and sub-elite European Caucasian marathon runners and 554 ethnically matched controls provided a DNA sample from which the ACTN3 R577X polymorphism was genotyped using real-time PCR. Personal best (PB) times were used to determine elite (men < 2 h 30 min, n = 111; women < 3 h 00 min, n = 105) or sub-elite (men 2 h 30 min – 2 h 45 min, n = 189; women 3 h 00 min – 3 h 15 min, n = 79) status. Genotype and allele frequencies were compared between athletes and controls using Chi-square analyses. One-way ANOVAs were implemented to identify any genotype-dependent differences in PB times for men and women, which were subject to correction for multiple comparisons.Results The X allele was ∼3% more frequent in the marathon runners than in non-athlete controls (see Table 1 and Figure 1), although this small difference did not approach statistical significance. There were no significant differences in genotype (χ2 = 3.40; P = 0.182) or allele (χ2 = 2.31; P = 0.128) frequency distributions between athletes (RR = 29.1%, RX = 50.6% XX = 20.2%; R = 54.4%, X = 45.6%) and controls. There were also no differences between elite and sub-elite genotype (P = 0.968, χ2 = 0.66) and allele frequencies (P = 0.916, χ2 = 0.11). Similarly, no differences in genotype or allele frequencies were found between either elite (P = 0.439, χ2 = 1.65; P = 0.265, χ2 = 1.24) or sub-elite (P = 0.254, χ2 = 2.74; P = 0.183, χ2 = 1.77) runners and the control group. Neither were PB times genotype-dependent for either men (P = 0.864) or women (P = 0.966).Conclusion No differences in genotype and allele frequencies were observed between athletes and controls, elite vs sub-elite, nor elite and sub-elite comparisons with the control group. Additionally, there was no genotype-dependent influence on PB time, which further emphasises that the ACTN3 R577X polymorphism does not influence elite endurance athlete status or determine marathon performance in European Caucasian runners. This is congruent with some previous findings and suggests other genetic variants or environmental factors may play a more prominent role in achieving elite endurance athlete status.
published_date 2016-11-18T04:03:20Z
_version_ 1763753277134995456
score 11.037166